Simulations Plus (NASDAQ:SLP) Given “Outperform” Rating at William Blair

Simulations Plus (NASDAQ:SLPGet Free Report)‘s stock had its “outperform” rating restated by equities researchers at William Blair in a research note issued on Thursday, Benzinga reports. William Blair also issued estimates for Simulations Plus’ Q4 2024 earnings at $0.06 EPS, FY2024 earnings at $0.54 EPS, Q2 2025 earnings at $0.19 EPS, Q4 2025 earnings at $0.19 EPS and FY2025 earnings at $0.67 EPS.

A number of other equities research analysts have also issued reports on SLP. JMP Securities began coverage on Simulations Plus in a research note on Tuesday, July 16th. They set a “market perform” rating for the company. Craig Hallum reissued a “buy” rating and set a $56.00 price target on shares of Simulations Plus in a research note on Wednesday, July 3rd. KeyCorp began coverage on Simulations Plus in a report on Monday, July 29th. They set an “overweight” rating and a $47.00 price objective on the stock. Finally, Oppenheimer raised their price objective on Simulations Plus from $55.00 to $65.00 and gave the stock an “outperform” rating in a report on Thursday, June 13th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $56.00.

Get Our Latest Stock Report on Simulations Plus

Simulations Plus Stock Performance

Shares of SLP stock opened at $32.50 on Thursday. Simulations Plus has a 52-week low of $32.22 and a 52-week high of $51.22. The firm has a market capitalization of $650.33 million, a P/E ratio of 67.71 and a beta of 0.70. The stock has a 50 day moving average price of $37.67 and a 200 day moving average price of $42.95.

Simulations Plus (NASDAQ:SLPGet Free Report) last issued its quarterly earnings results on Tuesday, July 2nd. The technology company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.04. Simulations Plus had a return on equity of 7.80% and a net margin of 14.36%. The firm had revenue of $18.54 million during the quarter, compared to analyst estimates of $17.92 million. During the same period last year, the company earned $0.20 EPS. Simulations Plus’s quarterly revenue was up 14.2% compared to the same quarter last year. As a group, sell-side analysts forecast that Simulations Plus will post 0.52 EPS for the current year.

Insider Activity

In related news, Director Daniel L. Weiner sold 750 shares of the business’s stock in a transaction on Friday, June 28th. The stock was sold at an average price of $49.32, for a total transaction of $36,990.00. Following the transaction, the director now directly owns 7,009 shares in the company, valued at approximately $345,683.88. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $39.63, for a total value of $792,600.00. Following the completion of the transaction, the director now owns 3,521,592 shares of the company’s stock, valued at approximately $139,560,690.96. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Daniel L. Weiner sold 750 shares of the business’s stock in a transaction dated Friday, June 28th. The shares were sold at an average price of $49.32, for a total value of $36,990.00. Following the completion of the transaction, the director now directly owns 7,009 shares of the company’s stock, valued at approximately $345,683.88. The disclosure for this sale can be found here. In the last three months, insiders have sold 60,750 shares of company stock worth $2,467,390. 20.90% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Simulations Plus

Institutional investors and hedge funds have recently modified their holdings of the business. EntryPoint Capital LLC purchased a new stake in Simulations Plus during the 1st quarter worth approximately $57,000. Allspring Global Investments Holdings LLC purchased a new stake in Simulations Plus during the 1st quarter worth approximately $70,000. Connecticut Wealth Management LLC purchased a new stake in Simulations Plus during the 1st quarter worth approximately $204,000. Los Angeles Capital Management LLC purchased a new stake in Simulations Plus during the 2nd quarter worth approximately $206,000. Finally, Janney Montgomery Scott LLC purchased a new stake in Simulations Plus during the 1st quarter worth approximately $208,000. Hedge funds and other institutional investors own 78.08% of the company’s stock.

About Simulations Plus

(Get Free Report)

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

Further Reading

Analyst Recommendations for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.